Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Nectar Life Care introduces affordable anti-diabetic medications, expands market presence
Nectar Life Care expands its diabetes care portfolio with the launch of Dapagliflozin and other anti-diabetic formulations,…
GenAI adoption in India’s pharma sector signals operational shifts
EY report highlights AI-driven efficiency in pharma and healthcare industries
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData
Novel therapies and regulatory shifts drive growth in the Duchenne muscular dystrophy market, with exon-skipping therapies leading…
Obesity market to reach $173.5 billion sales in 7MM by 2031, forecasts GlobalData
Growing patient awareness and emerging therapies drive obesity drug market expansion across the US, Europe, and Japan
Zydus Lifesciences partners with Zhuhai Beihai Biotech for BEIZRAY commercialisation in the US
Zydus to handle US market launch of Albumin Solubilized Docetaxel injection
Evolution and commercialisation of cell and gene therapies
Satyen Sanghavi, Founder & CSO, Regrow Biosciences traces the evolution of cell and gene therapies, highlighting global…
Jubilant Biosys seals deal with Pierre Fabre SA
Acquisition strengthens capabilities in biologics, ADCs, and integrated drug discovery
Rusan Pharma Chairman Dr Navin Saxena receives Russia’s ‘Order of Friendship’ and ‘Memorial Medal’
Honours recognise contributions to science, medicine, and Indo-Russian collaboration
Glenmark Pharmaceuticals launches Latanoprost Ophthalmic Solution in the US
Latanoprost Ophthalmic Solution, 0.005 per cent introduced as a bioequivalent alternative to Xalatan
Machine learning model developed to predict brain amyloid beta accumulation
Oita University and Eisai introduce a model for primary care physicians to facilitate early screening for Alzheimer’s disease